• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Inozyme Pharma Announces JBMR Plus Publication on ENPP1 Deficiency

    GLOBENEWSWIRE

    Inozyme Reports FY24, Prioritizes ENPP1 Deficiency Program

    GLOBENEWSWIRE

    Inozyme Pharma to Participate in Piper Sandler Healthcare Conf.

    GLOBENEWSWIRE

    Inozyme Publishes Preclinical Data Supporting INZ-701 For Rare Diseases

    GLOBENEWSWIRE

    Inozyme`s INZ-701 Receives FDA Fast Track For ABCC6 Deficiency

    GLOBENEWSWIRE

    Inozyme ICCBH Sponsored Symposium Children`s Bone Health

    GLOBENEWSWIRE

    Inozyme Pharma Announces Peer-Reviewed Publication Revealing Prevalence of ENPP1

    GLOBENEWSWIRE

    Rare disease biotech Inozyme Pharma files for an $86 million IPO

    NASDAQ

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.